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Abstract
Introduction
Despite a reduction in poor outcomes in recent decades, spontaneous subarachnoid haem-
orrhage (SAH) remains associated with severe disability and high mortality rates. The exact
extent of these outcomes is however unknown in Africa. This study aimed to determine the
mortality and functional outcomes of patients with SAH in Kenya.
Methods
We conducted a retrospective multicentre cross-sectional study involving patients admitted
with SAH to three referral hospitals in Nairobi. All patients with a confirmed (primary) dis-
charge diagnosis of first-time SAH between January 2009 and November 2017 were
included (n = 158). Patients who had prior head trauma or cerebrovascular disease (n = 53)
were excluded. Telephone interviews were conducted with surviving patients or their next of
kin to assess out-of-hospital outcomes (including functional outcomes) based on modified
Rankin Scale (mRS) scores. Chi-square and Fisher’s exact tests were used to assess asso-
ciations between mortality and functional outcomes and sample characteristics.
Results
Of the 158 patients sampled, 38 (24.1%) died in hospital and 42 (26.6%) died within 1
month. In total, 87 patients were discharged home and followed-up in this study, of which 72
reported favourable functional outcomes (mRS�2). This represented 45.6% of all patients
who presented alive, pointing to high numbers of unfavourable outcomes post SAH in
Kenya.
Conclusions
Mortality following SAH remains high in Kenya. Patients who survive the initial ictus tend to
do well after treatment, despite resource constraints.
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Limitations
The study findings should be interpreted with caution because of unavoidable limitations in
the primary data. These include its retrospective nature, the high number of patients lost to
follow up, missing records and diagnoses, and/or possible miscoding of cases.
Introduction
Spontaneous subarachnoid haemorrhage (SAH) is associated with severe disability and high
mortality rates; despite a reduction in case fatality rates over the last four decades [1]. Recent
studies have reported mortality rates from 25% at pre-hospital [2] to 18% in hospital [3]. Mor-
tality also remains high after discharge from hospital, with rates of 40% within 30 days [4],
50% within 1 year [5] and an elevated long-term mortality [6]. Only half of patients with SAH
who get to the hospital return to their previous level of functioning. The remainder are plagued
by numerous complications, from gross neurological deficits to subtle cognitive and neurobe-
havioural difficulties that hinder normal functioning and lower quality of life [7,8].
SAH in sub-Saharan Africa accounts for approximately 10–16% of all stroke subtypes
[9,10]. Autopsy studies show that it contributes to 2% of all unexplained non-violent deaths
and nearly 16% of all cardiovascular causes of deaths in Kenya [11]. This is despite only a third
of patients in some stroke studies having radiological confirmation [10] and an even smaller
number having angiographies [12]. As a result, SAH in sub-Saharan Africa is diagnosed late
[13]. This, coupled with delayed presentation [14], limited neurosurgical services and treat-
ment options [13], and high cost of care, mean that a majority of patients are untreated, and a
good number expire [15]. After a protracted hospital stay being conservatively managed, oth-
ers end up with poor neurological outcomes [13]. Although reports in Kenya point to a high
case fatality [15–17], the extent to which spontaneous subarachnoid haemorrhage patients sur-
vive and function after discharge, have not been studied. Therefore, we aimed to determine
the mortality and functional outcomes of patients with SAH in Kenya.
Methods
Study design and setting
We conducted a retrospective multicentre cross-sectional study to clarify the outcomes of
patients with SAH in Kenya. This study was conducted in one public and two private referral
hospitals located in Nairobi city. These three hospitals are some of the largest referral hospitals
in the country and offer both outpatient and inpatient services, including neurosurgical and
neuro-intensive care.
Sample and data collection
All adult and child patients with a primary confirmed discharge diagnosis of first-time SAH
(International Classification of Diseases, tenth revision: I60) and admitted to the selected hos-
pitals between January 2009 and November 2017 were included. We excluded all cases of intra-
cerebral haemorrhage with subarachnoid extension and those with a documented history of
head trauma. We identified 379 cases of SAH (324 in public and 55 in private hospitals). Data
were retrieved for 158 cases because 168 files were missing, and 53 cases were excluded. Hospi-
tal records for 2009 in the private hospitals and 2011–2012 in the public hospital were lost; as
such, these cases could not be assessed (Fig 1).
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The principal investigator and four trained research assistants retrieved available files from
the hospital medical records departments. Data on patients’ sociodemographic characteristics,
contact information, medical history, clinical presenting features and modes of treatment were
extracted from hospital records and patients’ files using a standardised data extraction tool.
Additional data on mortality and functional outcomes were collected from patients or their
next of kin. This information was collected via telephone interviews. All participating patients/
next of kin provided verbal informed consent, and the interviews were conducted by the prin-
cipal investigator using an encrypted telephone to ensure confidentiality.
Case definition
SAH was defined as a suggestive history (including but not limited to) a history of abrupt
onset of a severe headache or unconsciousness with or without signs of meningeal irritation or
focal neurological signs supported by computed tomography, lumbar puncture or necropsy
evidence of SAH.
Fig 1. Study sample. �Files from the public hospital for the years 2011 and 2012 were untraceable. Similarly, files in the private hospitals were
untraceable for the year 2009. ICH: intracerebral haemorrhage; SAH: subarachnoid haemorrhage.
https://doi.org/10.1371/journal.pone.0217832.g001
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Measures
The main outcomes for this study were in-hospital and 1-month post-discharge mortality
rates. The secondary outcome was functional outcomes measured using modified Rankin
Scale (mRS) scores; mRS scores�2 were classified as favourable and mRS scores of 3–6 were
considered unfavourable. Exposure measures included: demographic characteristics; present-
ing clinical, radiological and angiography features; and treatment modes.
Statistical analysis
STATA version 13 was used for the statistical analyses, with the significance level set at
p<0.05. Descriptive statistics were used to describe the sample characteristics, mortality and
functional outcomes. Associations between in-hospital mortality and functional outcomes and
sample characteristics were assessed using chi-square and Fisher’s exact tests.
Ethics
Ethical approval was obtained from the Kenyatta National Hospital, University of Nairobi Eth-
ics Review Board (Ref: KNH–UON/P319/06/2017). Permission to conduct the study was
granted by all the three participating hospitals before the study started. Informed verbal con-
sent was provided by all participating patients or their next of kin before telephone interviews,
and an encrypted telephone line used for the interviews. All collected data were de-identified,
and serial numbers were used for data collection.
Results
Sample characteristics
In total, 158 patients with SAH were included in this study. A majority were female (n = 91,
57.6%), the mean age was 48.6 (standard deviation [SD], 15.9; Range: 10–93) years and most
were from the public hospital (n = 121, 76.6%). There was an almost equal number of old (�50
years) and young (<50 years) patients (49% vs. 51%), and of those with/without hypertension
(52% vs. 48%). Patients presented with acute headache (86.5%), depressed consciousness
(53.2%), neck pain or stiffness (43.6%), seizures (21.8%) and focal neurological deficits
(13.5%). The modal admission Glasgow coma scale (GCS) score was 13–15 (68.35%) and the
average systolic blood pressure was 148.5 mmHg (SD, 29.6 mmHg). Most patients were dis-
charged with a GCS of 13–15 (95.3%). There were no significant differences in patient charac-
teristics between private and public hospitals except for alcohol use which was more among
patients in the public hospital (p = 0.006) and admission systolic blood pressure which was
higher among patients in the private hospital (p = 0.043) (Table 1).
SAH types and management
A total of 91 (57.6%) patients, 52 (49.2%) in public and 32 (84.2%) in private hospitals under-
went a cerebral angiogram. Forty-three patients (47.2%) had a digital subtraction angiogram,
41 (45.1%) had a computed tomography angiogram and the remainder had a magnetic reso-
nance angiogram. Sixty patients (38%) and 31 (19.6%) had a positive and negative angiogram
results. Aneurysm was identified in 61.5% (n = 56) of the 91 patients who underwent a cerebral
angiogram, with most being in the anterior circulation (n = 24, 42.9%) and of medium (n = 8,
50%) or small sizes (n = 7, 44%). Four patients, two males and two females below 50 years of
age of those with positive angiogram had arteriovenous malformations (Tables 1 and 2). Sixty-
seven (42.4%) of all SAH patients, a majority of who were female, aged�50 years and seen in
public hospital did not undergo cerebral angiogram.
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Table 1. Sample characteristics by hospital type a.
Variables Private n (%) Public n (%) Total n (%) p-value
Demographic and clinical characteristics Sex
Male 20 (54.1) 47 (38.8) 67 (42.4) 0.101
Female 17 (45.9) 74 (61.2) 91 (57.6)
Age
<50 years 19 (52.8) 61 (50.4) 80 (51.0) 0.803
�50 years 17 (47.2) 60 (49.6) 77 (49.0)
History of hypertension b (n = 153) 14 (37.8) 65 (53.7) 79 (50.0) 0.166
Tobacco use (n = 127) b 4 (15.4) 14 (13.9) 18 (14.2) 0.763
Alcohol use (n = 126) b 12 (46.2) 20 (20.0) 32 (25.4) 0.006�
Depressed consciousness b 19 (51.4) 64 (53.8) 83 (53.2) 0.796
Seizures b 8 (21.6) 26 (21.8) 34 (21.8) 0.977
Headache b 32 (86.5) 103 (86.5) 135 (86.5) 0.992
Neck pain or stiffness b 11 (29.7) 57 (47.9) 68 (43.6) 0.052
Focal neurological deficits b 21 (13.5) 21 (13.5) 21 (13.5) 0.275
Ictus to presentation, days c 3 (1–5) 4 (2–7) 4 (2–7) 0.126
Admission SBP (n = 156), mean (SD) 152 (34.1) 147.5 (28.1) 148.5 (29.6) 0.043�
Admission GCS (n = 155)
3–8 3 (8.3) 15 (12.6) 18 (11.6) 0.111
9–12 3 (8.3) 26 (21.8) 29 (18.7)
13–15 30 (83.3) 78 (65.6) 108 (69.7)
Radiological features Modified Fisher’s score (n = 38)
1 6 (16.2) 0 (0.0) 6 (3.8)
2 3 (8.1) 2 (1.7) 5 (3.2) 0.088
3 5 (13.5) 8 (6.6) 13 (8.2)
4 7 (18.9) 7 (5.8) 14 (8.9)
Missing score 16 (43.2) 104 (86.0) 120 (76.0)
Hydrocephalus (n = 90) 11 (57.9) 18 (25.4) 29 (32.2)
Angiography Angiogram status (n = 91)
Positive d 23 (62.2) 37 (30.6) 60 (38.0) 0.215
Negative 9 (24.3) 22 (18.2) 31 (19.6)
Not Done 5 (13.5) 62 (51.2) 67 (42.4)
Angiogram type (n = 91)
Computed tomography 26 (81.3) 15 (25.4) 41 (45.1) <0.001�
Magnetic resonance 1 (3.1) 6 (10.2) 7 (7.7)
Digital subtraction 5 (15.6) 38 (64.4) 43 (47.2)
Aneurysm location (n = 56) e
Anterior (ACA/AcoA) 11 (47.8) 15 (39.5) 24 (42.9) 0.832
Middle (MCA) 6 (26.1) 8 (21.1) 11 (19.6)
Internal (ICA/PcoA) 4 (17.4) 7 (18.4) 11 (19.6)
Posterior (PCA/VA) 0 (0.0) 2 (5.3) 1 (0.02)
Multiple 2 (8.7) 6 (15.8) 9 (16.1)
Aneurysm size (n = 56)
Small 6 (26.1) 1 (3.0) 7 (12.5) 0.350
Medium 7 (30.4) 1 (3.0) 8 (14.3)
Large 0 (0.0) 1 (3.0) 1 (1.8)
Missing 10 (43.5) 30 (90.9) 40 (71.4)
(Continued)
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Patients were managed either conservatively (79%, n = 124) or with surgical clipping
(n = 27, 17.2%) after presenting to hospital 4 median days (interquartile range [IQR], 5 days)
after the ictus. Six patients were transferred to other hospitals for coiling (3.8%), as this was
not available in the study hospitals. Both public and private hospitals had delays in initiating
definitive treatment, but the delays were significantly longer in public than private hospitals
(median days from ictus to clipping: 19 days vs. 5.5 days, p = 0.006) (Table 1).
Overall mortality and functional outcomes
The overall in-hospital mortality rate was 24.1% (n = 38) and the 1-month post-ictus mortality
rate was 26.6% (n = 42). An almost equal number of males and females died in hospital [mean
6 days (Range, 4–15 days)]. Patients aged�50 years had a significantly higher in-hospital mor-
tality rate than those aged <50 years (64.9% vs. 35.1%; p = 0.03). The median length of hospital
stay was 8 days (IQR, 4–21) for non-survivors and 12 days (IQR, 8–17) for survivors (Table 2).
Severity of ictus at admission was significantly associated to in-hospital mortality.
Assessment of functional outcomes targeted the 120 (75.9%) patients who were discharged.
However, only 87 (72.5% of discharged patients, 55% of total patients) patients or next of kin
could be reached via telephone. At follow up- six months to nine years after ictus, most patients
discharged from hospital had favourable functional outcomes at follow up (n = 72; 82.8%, 95%
CI: 74.7%–90.9%), with 17.2% (95% CI: 9.1%–25.3%) having unfavourable functional out-
comes. This represented 45.6% of all patients who presented alive having favourable functional
outcomes while 33.5% either died or were dependent and 21% were lost to follow-up (Fig 2).
A majority of patients with favourable functional outcomes were: female (n = 37, 51.4%),
younger than 50 years (n = 40, 55.6%), had significantly lower average systolic blood pressure
at admission (142 mmHg, SD: 27 mmHg) and a discharge GCS of 13–15 and had positive
angiogram (n = 27, 38.6%). There were no significant differences in the functional outcomes
Table 1. (Continued)
Variables Private n (%) Public n (%) Total n (%) p-value
Management Mode of treatment
Conservative 17 (46.0) 108 (89.3) 125 (79.1) <0.001�
Clip 14 (37.8) 13 (10.7) 27 (17.1)
Referral (for coiling) 6 (16.2) 0 (0.0) 6 (3.8)
Days from ictus to clipping 5.5 (2–9) 19 (11–58) 9 (4–20.5) 0.006�
Length of hospital stay 9 (7–15) 11 (5–21) 10.5 (5–21) 0.250
Discharge GCS
3–8 2 (6.4) 1 (1.3) 3 (2.8) 0.234
9–12 0 (0.0) 2 (2.6) 2 (1.9)
13–15 29 (93.6) 73 (96.1) 102 (95.3)
ACA: anterior cerebral artery; AcoA: anterior communicating artery; GCS: Glasgow Coma Scale; ICA: internal carotid artery; MCA: middle cerebral artery; PCA:
posterior cerebral artery; PcoA: posterior communicating artery; SAH: subarachnoid haemorrhage; SD: standard deviation; SBP: systolic blood pressure; VA: vertebral
artery;
� statistically significant at p = 0.05
a Detailed table with the missing values is available S1 Table
b Includes only the YES responses [Detailed results are available in S1 Table]
c Median (range/interquartile range)
d Includes 4 arteriovenous malformations
e Only patients with angiogram positive are included
https://doi.org/10.1371/journal.pone.0217832.t001
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between public and private hospitals (p = 0.53) (Table 2). Sex, admission systolic blood pres-
sure, admission and discharge clinical status, presence of hydrocephalus and angiography sta-
tus were significantly associated with functional outcomes as shown in Table 2 above.
Outcomes by SAH type
Among 56 aneurysmal SAH patients, 26 (55%) were actively treated by microsurgical aneurys-
mal clipping and 25 (44.6%) were conservatively treated. Six patients (one non-aneurysmal
Table 2. In-hospital and functional outcomes by sample characteristics.
Variables In-hospital mortality (n = 158) Functional outcomes (n = 87)c
Dead (n, %) Alive (n, %) p-value Favourable (n, %) Unfavourable (n, %) p-value
Hospital type
Public 33 (86.8) 88 (73.3) 0.09 52 (81.3) 12 (18.7) 0.53
Private 5 (13.2) 32 (26.7) 20 (87.0) 3 (13.0)
Sex
Male 18 (47.4) 49 (40.8) 0.48 35 (48.6) 3 (20.0) 0.05�
Female 20 (52.6) 71 (59.2) 37 (51.4) 12 (80.0)
Age
<50 years 13 (35.1) 67 (55.8) 0.03 40 (55.6) 5 (33.3) 0.16
�50 years 24 (64.9) 53 (44.2) 32 (44.4) 10 (66.7)
Admission SBP, mmHg [mean (SD)] 149.5 (28.0) 148.2 (30.2) 0.81 142.7 (27.0) 164.1 (26.4) �
Admission GCS
3–8 14 (37.8) 4 (3.4) <0.01� 2 (2.9) 0 (0.0) <0.01�
9–12 12 (32.4) 17 (14.4) 4 (5.7) 5 (33.3)
13–15 11 (29.7) 97 (82.2) 64 (91.4) 10 (66.7)
Hydrocephalus 9 (47.4) 20 (28.2) 0.11 9 (20.0) 5 (50.0) 0.05�
Angiogram Status
Positive (n = 56) a 7 (18.4) 49 (42.2) 0.48 27 (38.6) 8 (53.3) 0.03�
Negative (n = 31) 1 (2.7) 30 (25.9) 20 (28.6) 0 (0)
Angiogram Not Done (n = 67) 30 (78.9) 37 (31.9) 23 (32.8) 7 (46.7)
Aneurysm size (n = 16)
Small 1 (33.3) 6 (46.2) >0.99 2 (28.6) 2 (66.7) 0.67
Medium 2 (66.7) 6 (46.2) 4 (57.1) 1 (33.3)
Large 0 (0.0) 1 (7.7) 1 (14.3) 0 (0.0)
Mode of treatment
Conservative 35(92.1) 90 (75.0) 0.10 53 (73.6) 12 (80.0) 0.29
Clip 3(7.9) 24 (20.0) 18 (25.0) 2 (13.3)
Referral (for coiling) 0 (0) 6 (5.0) 1 (1.4) 1 (6.7)
Length of hospital stay, days b 8 (4–21) 12 (8–17) 0.03� 11.5 (8–16.5) 13 (8–47) 0.23
Discharge GCS
3–8 1 (33.3) 2 (1.9) 0.14 0 (0.0) 2 (18.2) 0.01�
9–12 0 (0.0) 2 (1.9) 1 (1.5) 1 (9.1)
13–15 2 (66.7) 100 (96.2) 68 (98.5) 8 (72.3)
GCS: Glasgow Coma Scale; SD: standard deviation; SBP: systolic blood pressure; SAH: subarachnoid haemorrhage; † median (range/interquartile range);
� statistically significant at p = 0.05
a Excludes the 4 arteriovenous malformations
b Median (range/interquartile range)
c Includes only 87 patients/next of kin who could be contacted; 33 of the discharged patients were lost to follow-up (Fig 2)
https://doi.org/10.1371/journal.pone.0217832.t002
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and five aneurysmal) were transferred out of the study hospitals and treatment data was subse-
quently unavailable. Of the 26 aneurysmal SAH patients treated, 17 (65.4%) were<50 years of
age, 14 (53.8% were in private hospitals, and 23 (88.5%) had a GCS of 13–15. The 25 conserva-
tively managed aneurysmal SAH patients were mostly female, older [�50 years], with longer
median days from ictus to presentation. More patients were definitively treated in private than
in public hospitals (78% vs. 36%, p = 0.005). A majority of aneurysmal SAH patients who were
treated survived (n = 24, 92.3%) and had favourable functional outcomes (n = 18, 75%)
(Table 3).
Thirty-one SAH patients in our study (19.6%) had a negative cerebral angiogram; a major-
ity of whom were younger than 50 years (55%) and had a GCS 13–15 at admission (80%).
Only one of these patients died in the hospital (3.2%). Of those discharged home, twenty
Fig 2. Pictorial representation of outcomes of SAH patients in our study. � percentages of all patients included in the study.
https://doi.org/10.1371/journal.pone.0217832.g002
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patients (65%) were reached and all of them had favourable outcomes. This group of patents
had the best outcomes- mortality and functional outcomes- of all three groups based on angi-
ography status (Tables 2 and 4 below).
Discussion
This study aimed to determine the mortality and functional outcomes of patients with sponta-
neous subarachnoid haemorrhage (SAH) in Kenya. We recorded 158 SAH cases over the
nine-year study period. This low number of SAH cases could be explained by the retrospective
nature of the study and possibly a large number of undiagnosed hence unreported SAH cases
resulting from a lack of neuroimaging and angiographic diagnostic tools for SAH as seen in
this study. This is also evidenced by the high proportion of autopsy identified SAH cases in
unexplained deaths in Kenya [11]. Moreover, for SAH patients who eventually get diagnosed,
record keeping in our region is deficient [18].
Our study found a relatively high overall mortality rate among patients with SAH of all
types, with in-hospital and 1-month mortality rates of 24% and 26.6%, respectively. In-hospital
mortality was highest for patients without angiography (44.8%) and least in the angiogram
negative group (3.2%). The overall mortality was higher compared to other studies including
aneurysmal and non-aneurysmal studies in the UK, Ireland and US where the rates reported
Table 3. Clinical, demographic and outcome data in 51 aneurysmal SAH b patients with and without definitive treatment.
Characteristics Treated (n, %) Untreated (n, %) p-value c
Number of patients 26 (55.4) 25 (44.6)
Hospital type
Public 12 (46.2) 21 (84.0) 0.005�
Private 14 (53.8) 4 (16.0)
Sex
Male 13 (50.0) 6 (24.0) 0.055
Female 13 (50.0) 19 (76.0)
Age
<50 years 17 (65.4) 9 (37.5) 0.049�
�50 years 9 (34.6) 15 (62.5)
Admission GCS
9–12 3 (11.5) 7 (29.2) 0.164
13–15 23 (88.5) 17 (70.8)
Length of hospital stay, days a (for survivors) 14 (10.5–24) 13.5 (6.5–24.5) 0.04�
Ictus to presentation, days a 3 (1–5) 3 (1.5–7.5) 0.78
In-hospital Mortality
Alive 24 (92.3) 20 (80.0) 0.248
Dead 2 (7.7) 5 (20.0)
Functional Outcomes
Favourable 18 (75.0) 9 (45.0)
Unfavourable 2 (8.3) 4 (20.0) 0.139
Dead/ Lost to follow-up 4 (16.7) 7 (35.0)
GCS: Glasgow Coma Scale;
a median (range/interquartile range);
b Patients transferred to other hospitals excluded;
c Association between the characteristics and the treatment status of aneurysmal SAH patients;
� statistically significant at p = 0.05
https://doi.org/10.1371/journal.pone.0217832.t003
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were between 11–18% [3,19]. This might result from delayed presentation as shown by pro-
tracted ictus to presentation times (mean 4 days), delayed treatment (mean 9 days) and high
numbers of untreated patients seen in this study.
For aneurysmal SAH patients, the in-hospital mortality rate was 11.7% which was much
lower compared with Saudi Arabia (15%) [20], in Morocco (18%) [14], and Nairobi, Kenya
(30%) [15]. This should however be interpreted in light of the limitations of this study and
may result from evident treatment bias. Conservatively managed aneurysmal SAH patients
had in-hospital mortality rates nearly three times that of surgically clipped patients (20% and
7.7%). Surgically clipped patients also had nearly two-fold favourable outcomes as compared
to the conservatively managed patients (75% and 45%). This is supported by existing literature
Table 4. Clinical, demographic and outcome data in 158 patients based on SAH type.
Factors Angiogram Status p-value
Not Done (n, %) Positive (n, %) a Negative (n, %)
Number of patients 67 (42.4) 60 (38.0) 31 (19.6)
Age [mean (SD)] 51.5 (18.2) 46.5 (13.5) 46.4 (14.2)
Hospital type
Public 62 (92.5) 37 (61.7) 22 (71.0) <0.01�
Private 5 (7.5) 23 (38.3) 9 (29.0)
Sex
Male 30 (44.8) 22 (36.7) 15 (48.4) 0.49
Female 37 (55.2) 38 (63.3) 16 (51.6)
Age
<50 years 17 (54.8) 34 (57.6) 17 (54.8) 0.25
�50 years 14 (45.2) 25 (42.4) 14 (45.2)
Admission GCS
3–8 14 (21.2) 0 (0.0) 4 (13.3)
9–12 16 (24.2) 11 (18.6) 2 (6.7) <0.01�
13–15 36 (54.6) 48 (81.4) 24 (80.0)
Length of hospital stay, daysb (for survivors) 9.5 (5–16) 14 (8–24) 12.5 (5–15) <0.01�
Ictus to presentation, daysb 4 (2.5–7) 3 (1–7) 3 (1–5) <0.01�
In-hospital Mortality
Dead 30 (44.8) 7 (11.7) 1 (3.2) <0.01�
Alive 37 (55.2) 53 (88.3) 30 (96.8)
Functional Outcomes
Favourable 23 (34.3) 29 (48.3) 20 (64.5)
Unfavourable 7 (10.5) 8 (13.3) 0 (0.0) 0.02�
Dead/ Lost to follow-up 37 (55.2) 23 (38.3) 11 (35.5)
Treatment
Conservative 66 (98.5) 29 (48.3) 29 (96.7) <0.01�
Clip 1 (1.5)�� 27 (43.3) 0 (0.0)
Referral 0 (0.0) 5 (8.3) 1 (3.3)
GCS: Glasgow Coma Scale; SD: standard deviation;
� statistically significant at p = 0.05;
a Includes 4 arteriovenous malformations
b Median (range/interquartile range)
��For one of the patients who underwent clipping, angiogram data was not recorded.
https://doi.org/10.1371/journal.pone.0217832.t004
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that indicate actively managed patients have lower mortality rates and better functional out-
comes compared with conservatively managed patients [21,22].
Compared with angiogram-negative SAH patients however, patients with aneurysmal SAH
had an in-hospital mortality rate four times higher (11.7% compared to 3.2%). This is compa-
rable with Elhadi et al.’s US study that reported zero in-hospital mortality, with 64% of patients
having a complete recovery at discharge and a short hospital stay (mean 9.5 days, range 2–27
days) for non-aneurysmal SAH patients [23]. The length of stay in our study was however
more protracted, with a mean of 12.5 days (range 5–15 days) for angiogram negative SAH
patients in our study.
Overall, majority of patients discharged from hospital who were followed up in our study
had favourable outcomes (83%) six or more months after ictus; this however represents only
45.6% of all the patients who presented alive; much lower than that recorded in other studies
(50–60%) in different regions [19,21]. Only 58% of patients had angiographies in our study
compared to over 90% in the high-income settings [22]; and subsequently, only 55% of the
aneurysmal SAH patients in our study were definitively treated (by surgical clipping); while
45% were untreated. This is unlike the 17–38% untreated cases reported in other studies [22]
and the large number of untreated patients may explain the worse outcomes reported in our
study. Additionally, for SAH patients who were actively treated, treatment was instituted 9
days from the ictus compared with 2.7 days in the UK [21]. The delay in treatment was sig-
nificantly longer in the public hospital where access to neurosurgical services and quality of
care is low. Public hospitals have limited neuro-intensive care, low access to neurosurgical
operation space, and no endovascular services [24] while private hospitals have better neuro-
surgical infrastructure but are costly for a majority of Kenyans [25]. Hence, the difference in
outcomes between public and private hospitals, and between Kenya and high-resourced
countries.
Although there are limited comparable studies in Africa, a 17-year retrospective review of
patients with intracranial aneurysms in Morocco reported a 64.5% favourable outcomes [14].
The differences in favourable functional outcomes could be explained by the differences in
inclusion criteria as the Moroccan study only included treated patients, as all conservatively
managed patients were lost to follow up. Considering only definitively-treated patients in our
study, nearly two-thirds (75%) of all surgically clipped patients had favourable functional out-
comes; which would be comparable to the Moroccan study, and similar retrospective studies
in Senegal and South Africa that reported a 64.7% and 66% favourable outcomes after surgical
clipping [13,26].
Our study had a higher number of angiogram-negative SAH cases (34%) compared with
other studies [27,28]. All of them experienced favourable outcomes comparable to other stud-
ies (83% [27] and 94% [29]). While this may be intriguing, it is noteworthy that none of these
angiogram negative SAH patients had a repeat angiogram to confirm the non-aneurysmal
SAH. The patients’ outcomes in our study were associated with the SAH type, severity of initial
bleed (admission GCS), admission blood pressure, discharge GCS, presence of hydrocephalus
and sex after univariate analysis. These factors have been shown to affect patient survival and
functional outcomes after SAH in other studies [19,21,30–32].
Limitations
To our knowledge, this is the first study in Kenya focusing on outcomes for patients after
SAH. This study was conducted in three major public and private hospitals in Nairobi, with a
relatively large representative sample of all SAH cases in Kenya. Therefore, our findings could
be generalisable to Kenya. This study also used a standardised definition for SAH and a
Outcomes after a subarachnoid haemorrhage in Kenya
PLOS ONE | https://doi.org/10.1371/journal.pone.0217832 June 12, 2019 11 / 14
pretested checklist to avoid misclassification bias and allow for comparability of the findings
and forms a basis for future large-scale prospective studies. However, despite its strengths, the
study had some limitations.
First, the study was retrospective and therefore has potential for information bias (e.g. recall
and misclassification bias). This was mitigated by using two data sources (medical files and
patient/next of kin interviews) but was not fully addressed because some patients were
unreachable. In addition, some data were missing, such as patients’ date of demise. There was
also a risk of misclassification bias because the study relied on the accuracy and reliability of
diagnoses made by other medical doctors. During the telephone interviews, there was also a
potential risk of responder bias.
Second, some of the secondary outcomes could not be assessed because of missing data,
which still is a common problem in our region due to reliance on paper-based records [18],
such as cases of re-bleeding and delayed ischaemic neurological deficits, the incidence of
symptomatic vasospasm, readmissions and mortality from other causes. Subsequently, there
was a high rate of loss of follow up, owing to the retrospective nature of the study and the miss-
ing data. As such, some conclusions couldn’t be concretely made.
Third, lack of local hospital guidelines/protocols on SAH management means that most
cases are totally determined by the attending physician, with minimal or no consultation. As
such, more younger patients with good admission clinical status and especially in private hos-
pitals were definitively treated indicating possible treatment bias. Lastly, due to lack of angio-
grams, it was difficult to characterize a significant number of SAH cases adequately. This was
further hampered by the retrospective nature of the study.
Conclusion
In-hospital and 1-month mortality rates for SAH are high in Kenya, and functional outcomes
are generally low. For patients who reach neurosurgical centres and are actively managed how-
ever, favourable functional outcomes are comparable to other centres; although given the limi-
tations of this study including treatment bias, this needs to be further studied.
As one of the first studies on the outcomes of patients with SAH in sub-Saharan Africa, this
study highlights the disparity in outcomes in SAH patients between low- and high-resourced
regions. This study forms a basis for further prospective studies to investigate other secondary
outcomes of SAH, such as readmissions and re-bleeding.
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